139 related articles for article (PubMed ID: 34087721)
1. The impact of the CervicalCheck controversy on provision of colposcopy services in Ireland: A cohort study.
Cheung M; Fitzpatrick M
Eur J Obstet Gynecol Reprod Biol; 2021 Jul; 262():228-231. PubMed ID: 34087721
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years.
Flannelly GM; Mooney MT; Greehy GM; Keogh EB; McNally SA; Fitzpatrick PE
Eur J Cancer Prev; 2018 Mar; 27(2):158-163. PubMed ID: 27824660
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
4. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
5. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M
Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948
[TBL] [Abstract][Full Text] [Related]
6. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
[TBL] [Abstract][Full Text] [Related]
7. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
8. Can biopsies be omitted after normal colposcopy in women referred with low-grade cervical cytology? A prospective cohort study.
Jespersen MM; Booth BB; Petersen LK
BMC Womens Health; 2021 Nov; 21(1):394. PubMed ID: 34798899
[TBL] [Abstract][Full Text] [Related]
9. Impact of colposcopy on management outcomes of patients with abnormal cervical cytology.
Koigi-Kamau R; Kabare LW; Machoki JM
East Afr Med J; 2007 Mar; 84(3):110-6. PubMed ID: 17600979
[TBL] [Abstract][Full Text] [Related]
10. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
11. Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
Nikolopoulos M; Athanasias P; Godfrey MAL; Nikolopoulos K; Maheshwari MK
Cytopathology; 2021 Nov; 32(6):751-757. PubMed ID: 34181788
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
13. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
[TBL] [Abstract][Full Text] [Related]
14. Are Women with Antecedent Low-Grade Cytology and <CIN2 Findings in Colposcopy Being Overmanaged?
Piedmonte S; Tsang K; Jembere N; Murphy J; McCurdy B; Sacco J; Kupets R
J Obstet Gynaecol Can; 2022 Oct; 44(10):1054-1060. PubMed ID: 35948169
[TBL] [Abstract][Full Text] [Related]
15. Does Cervical Screening in Young Women Aged 20-25 Years Lead to Unnecessary and Harmful Interventions?
Al-Kalbani M; Price J; Thompson G; Ahmad S; Nagar H
Asian Pac J Cancer Prev; 2015; 16(15):6557-9. PubMed ID: 26434874
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
[TBL] [Abstract][Full Text] [Related]
17. HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.
Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Cotton S; Nicoll S; Robertson C
Br J Cancer; 2016 Mar; 114(5):582-9. PubMed ID: 26931370
[TBL] [Abstract][Full Text] [Related]
18. The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.
Munro A; Gillespie C; Cotton S; Busby-Earle C; Kavanagh K; Cuschieri K; Cubie H; Robertson C; Smart L; Pollock K; Moore C; Palmer T; Cruickshank ME
BJOG; 2017 Aug; 124(9):1394-1401. PubMed ID: 28102931
[TBL] [Abstract][Full Text] [Related]
19. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
